Alterations in adrenergic receptor signaling in heart failure
- PMID: 16228912
- DOI: 10.1023/A:1009885822076
Alterations in adrenergic receptor signaling in heart failure
Abstract
In the failing heart, several changes occur in cardiac adrenergic receptor-signal transduction pathways. The most striking of these changes occur in beta-ARs, and of the changes in beta-adrenergic receptors, beta1-receptor down-regulation is the most prominent. Other changes include uncoupling of beta2-adrenergic receptors and increased activity of the inhibitory G-protein, Gi. Most of these changes appear to be related to increased activity of the adrenergic nervous system, i.e. increased exposure to norepinephrine. Antagonists of the adrenergic nervous system improve left ventricular function and outcome in patients with heart failure. This fact supports the notion that activation of these neurohormonal systems exerts a net long-term detrimental effect on the natural history of chronic heart failure and that myocardial adrenergic desensitization phenomena are at least partially adaptive in the setting of left ventricular dysfunction.
Similar articles
-
[Pathophysiology of chronic heart failure].Clin Res Cardiol. 2006;95 Suppl 4:1-15; quiz 16-7. doi: 10.1007/s00392-006-2005-z. Clin Res Cardiol. 2006. PMID: 16598604 Review. German.
-
Changes in myocardial and vascular receptors in heart failure.J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):61A-71A. doi: 10.1016/0735-1097(93)90465-d. J Am Coll Cardiol. 1993. PMID: 8397233 Review.
-
The beta-adrenergic receptors.Herz. 2002 Nov;27(7):683-90. doi: 10.1007/s00059-002-2434-z. Herz. 2002. PMID: 12439640 Review.
-
Beta-adrenergic receptors and receptor signaling in heart failure.Annu Rev Pharmacol Toxicol. 1999;39:343-60. doi: 10.1146/annurev.pharmtox.39.1.343. Annu Rev Pharmacol Toxicol. 1999. PMID: 10331088 Review.
-
Adrenergic mechanisms in congestive heart failure.Acta Med Scand Suppl. 1986;707:37-44. Acta Med Scand Suppl. 1986. PMID: 2874691 Review.
Cited by
-
Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.Curr Hypertens Rep. 2016 Jul;18(7):51. doi: 10.1007/s11906-016-0660-7. Curr Hypertens Rep. 2016. PMID: 27193773 Review.
-
Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure.Heart Fail Rev. 2020 Sep;25(5):685-701. doi: 10.1007/s10741-019-09860-8. Heart Fail Rev. 2020. PMID: 31637568 Review.
-
[Cardiac sequelae of hypertension].Internist (Berl). 2009 Apr;50(4):397-409. doi: 10.1007/s00108-008-2289-3. Internist (Berl). 2009. PMID: 19343394 Review. German.
-
Cardiac Dysfunction Induced by Obesity Is Not Related to β-Adrenergic System Impairment at the Receptor-Signalling Pathway.PLoS One. 2015 Sep 21;10(9):e0138605. doi: 10.1371/journal.pone.0138605. eCollection 2015. PLoS One. 2015. PMID: 26390297 Free PMC article.
-
Perioperative Supplemental Oxygen and Plasma Catecholamine Concentrations after Major Abdominal Surgery-Secondary Analysis of a Randomized Clinical Trial.J Clin Med. 2022 Mar 22;11(7):1767. doi: 10.3390/jcm11071767. J Clin Med. 2022. PMID: 35407374 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical